Advertisement
Advertisement
U.S. markets close in 2 hours 39 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Kazia Therapeutics Limited (KZIA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
10.10+0.20 (+2.02%)
As of 1:02PM EST. Market open.
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 11/29/2021
Current
Market Cap (intraday) 5
130.68M
Enterprise Value 3
110.89M
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
4.81
Enterprise Value/Revenue 3
7.30
Enterprise Value/EBITDA 7
-21.69

Trading Information

Stock Price History

Beta (5Y Monthly) 2.66
52-Week Change 3-0.90%
S&P500 52-Week Change 326.87%
52 Week High 314.89
52 Week Low 38.48
50-Day Moving Average 311.03
200-Day Moving Average 310.45

Share Statistics

Avg Vol (3 month) 326.14k
Avg Vol (10 day) 320.54k
Shares Outstanding 513.2M
Implied Shares Outstanding 6N/A
Float 89.63M
% Held by Insiders 10.00%
% Held by Institutions 14.31%
Shares Short (Nov 14, 2021) 42.39k
Short Ratio (Nov 14, 2021) 40.11
Short % of Float (Nov 14, 2021) 4N/A
Short % of Shares Outstanding (Nov 14, 2021) 40.02%
Shares Short (prior month Oct 14, 2021) 43.71k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jul 13, 2017
Ex-Dividend Date 4N/A
Last Split Factor 21:4
Last Split Date 3Jul 13, 2017

Financial Highlights

Currency in AUD.

Fiscal Year

Fiscal Year Ends Jun 29, 2021
Most Recent Quarter (mrq)Jun 29, 2021

Profitability

Profit Margin -55.47%
Operating Margin (ttm)-42.01%

Management Effectiveness

Return on Assets (ttm)-9.83%
Return on Equity (ttm)-32.41%

Income Statement

Revenue (ttm)15.18M
Revenue Per Share (ttm)1.29
Quarterly Revenue Growth (yoy)4,088.80%
Gross Profit (ttm)15.18M
EBITDA -5.11M
Net Income Avi to Common (ttm)-8.42M
Diluted EPS (ttm)-0.51
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)27.59M
Total Cash Per Share (mrq)2.09
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.53
Book Value Per Share (mrq)2.87

Cash Flow Statement

Operating Cash Flow (ttm)-9.11M
Levered Free Cash Flow (ttm)1.26M
Advertisement
Advertisement